NZ594973A - Methods for the detection of JC polyomavirus and diagnosis of progressive multifocal leukoencephalopathy (PML) - Google Patents

Methods for the detection of JC polyomavirus and diagnosis of progressive multifocal leukoencephalopathy (PML)

Info

Publication number
NZ594973A
NZ594973A NZ594973A NZ59497310A NZ594973A NZ 594973 A NZ594973 A NZ 594973A NZ 594973 A NZ594973 A NZ 594973A NZ 59497310 A NZ59497310 A NZ 59497310A NZ 594973 A NZ594973 A NZ 594973A
Authority
NZ
New Zealand
Prior art keywords
pml
polyomavirus
progressive multifocal
multifocal leukoencephalopathy
diagnosis
Prior art date
Application number
NZ594973A
Other languages
English (en)
Inventor
Leonid Gorelik
Alexey Lugovskoy
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42542341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ594973(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Publication of NZ594973A publication Critical patent/NZ594973A/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/025Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
NZ594973A 2009-02-05 2010-02-05 Methods for the detection of JC polyomavirus and diagnosis of progressive multifocal leukoencephalopathy (PML) NZ594973A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15031009P 2009-02-05 2009-02-05
PCT/US2010/000342 WO2010090757A1 (en) 2009-02-05 2010-02-05 Methods for the detection of jc polyoma virus

Publications (1)

Publication Number Publication Date
NZ594973A true NZ594973A (en) 2012-05-25

Family

ID=42542341

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ594973A NZ594973A (en) 2009-02-05 2010-02-05 Methods for the detection of JC polyomavirus and diagnosis of progressive multifocal leukoencephalopathy (PML)

Country Status (11)

Country Link
US (2) US20130101985A9 (enExample)
EP (1) EP2394163B1 (enExample)
JP (1) JP2012517017A (enExample)
CN (2) CN104316696A (enExample)
AU (1) AU2010210979B2 (enExample)
BR (1) BRPI1016273A2 (enExample)
CA (1) CA2751364C (enExample)
ES (1) ES2842425T3 (enExample)
NZ (1) NZ594973A (enExample)
SG (2) SG173201A1 (enExample)
WO (1) WO2010090757A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE047230T2 (hu) 2006-02-28 2020-04-28 Biogen Ma Inc Gyulladásos és autoimmun betegségek natalizumabbal való kezelésének módszerei
AU2007224228B2 (en) 2006-03-03 2013-09-19 Biogen Ma Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
WO2010090757A1 (en) 2009-02-05 2010-08-12 Biogen Idec Ma Inc. Methods for the detection of jc polyoma virus
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
PT2524060T (pt) 2010-01-11 2018-03-28 Biogen Ma Inc Ensaio para a deteção de anticorpos contra o vírus jc
PT3575792T (pt) 2011-05-31 2023-02-28 Biogen Ma Inc Método de avaliação do risco de lmp
PT2734544T (pt) 2011-07-18 2021-03-16 Us Health Métodos e composições para inibir a patologia associada a poliomavírus
EP2548567A1 (en) 2011-07-22 2013-01-23 Universitätsklinikum Hamburg-Eppendorf Polyoma virus JC peptides and proteins in vaccination and diagnostic applications
EP2636746A1 (en) * 2012-03-06 2013-09-11 Life Science Inkubator A novel drug delivery system based on JCV-VLP
DK2828292T3 (da) 2012-03-20 2019-01-02 Biogen Ma Inc Jcv-neutraliserende antistoffer
DK2828284T3 (da) 2012-03-20 2019-06-11 Biogen Ma Inc Jcv-neutraliserende antistoffer
US9631243B2 (en) 2012-06-18 2017-04-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for identifying JC virus
CN104936980B (zh) 2012-12-31 2019-06-07 生物控股有限公司 用于治疗和预防多瘤病毒相关的疾病的重组人抗体
NO2774991T3 (enExample) * 2013-03-06 2018-05-05
US20160002743A1 (en) * 2013-03-15 2016-01-07 Biogen Ma Inc. High resolution melting analysis assay for the detection of viral dna
EP3004334A4 (en) 2013-05-28 2016-12-21 Biogen Ma Inc METHOD FOR ASSESSING A PML RISK
WO2015095770A1 (en) 2013-12-20 2015-06-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogenic jc polyomavirus compositions and methods of use
US20200197544A1 (en) * 2017-04-26 2020-06-25 Biogen Ma Inc. Jcv imaging methods and compositions
CN112442553A (zh) * 2020-10-27 2021-03-05 深圳市罗湖区人民医院 一种用于JCPyV检测与分型的试剂盒及方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3767755B2 (ja) * 1995-06-23 2006-04-19 エーザイ株式会社 抗jcウイルス抗体
DE19543553B4 (de) * 1995-11-22 2009-04-09 Deutsches Primatenzentrum Gmbh VP-Antigene des JC-Virus
AU715973B2 (en) 1996-01-26 2000-02-10 Regents Of The University Of California, The Polymeric film, assay and method for direct colorimetric detection of analytes
DE10131145B4 (de) * 2001-06-28 2005-07-14 Innovent E.V. Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen
JP4840792B2 (ja) 2001-11-22 2011-12-21 独立行政法人科学技術振興機構 JCウイルスagnoを対象としたPMLの治療
EP1785433A4 (en) 2004-07-01 2008-10-01 Tokyo Inst Tech VIRAL PARTICLE-LIKE CONSTRUCTION AND PROCESS FOR FORMING THE SAME IN PHYSIOLOGICAL CONDITIONS
JP4757103B2 (ja) 2005-06-13 2011-08-24 学校法人関西文理総合学園 試料中のウイルスを検出する方法およびシステム
US7468186B2 (en) 2005-07-22 2008-12-23 City Of Hope Polyomavirus cellular epitopes and uses therefor
EP1951888B1 (en) 2005-11-09 2012-09-05 PrimeraDx, Inc. Multiplexed quantitative detection of pathogens
US7769230B2 (en) * 2006-11-30 2010-08-03 Eastman Kodak Company Producing low resolution images
WO2008077511A1 (en) 2006-12-22 2008-07-03 Karolinska Institutet Innovations Ab Human polyomavirus and methods of diagnosis and treatment
JP2008249433A (ja) 2007-03-29 2008-10-16 Kansai Bunri Sogo Gakuen 被験物質に対するプローブの結合親和性を測定する方法及びその利用
US20110118340A1 (en) 2008-02-08 2011-05-19 Muthiah Manoharan Delivery of rnai constructs to oligodendrocytes
WO2010090757A1 (en) 2009-02-05 2010-08-12 Biogen Idec Ma Inc. Methods for the detection of jc polyoma virus
EA201490368A1 (ru) 2011-07-29 2014-07-30 Байоджен Айдек Ма Инк. Анализ для определения днк вируса jc
AR095089A1 (es) 2013-01-30 2015-09-30 Biogen Idec Inc Ensayo de detección de adn de virus jc

Also Published As

Publication number Publication date
US9696307B2 (en) 2017-07-04
EP2394163B1 (en) 2020-08-19
US20120258443A1 (en) 2012-10-11
US20150219651A1 (en) 2015-08-06
US20130101985A9 (en) 2013-04-25
SG2014009120A (en) 2014-03-28
CN102369436B (zh) 2014-10-22
CA2751364C (en) 2017-06-20
SG173201A1 (en) 2011-08-29
AU2010210979A1 (en) 2011-09-22
AU2010210979B2 (en) 2015-12-10
BRPI1016273A2 (pt) 2020-12-01
EP2394163A1 (en) 2011-12-14
EP2394163A4 (en) 2012-08-01
WO2010090757A1 (en) 2010-08-12
CN102369436A (zh) 2012-03-07
ES2842425T3 (es) 2021-07-14
CN104316696A (zh) 2015-01-28
JP2012517017A (ja) 2012-07-26
CA2751364A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
CN102816763B (zh) 特异性结合于疟原虫乳酸脱氢酶pLDH的DNA适体
IL192866A (en) Detecting cancer with high levels of 2 bcl
JP2013516633A5 (enExample)
FI4152004T3 (fi) Jc-viruksen vasta-aineiden määritys
SI2046985T1 (sl) Postopek za odkrivanje EGFR mutacij v krvnih vzorcih
EP2394163A4 (en) PROCEDURE FOR DETECTION OF THE JC POLYOMAVIRUS
JP2011512817A5 (enExample)
WO2013009703A8 (en) Antibodies, kit and method for detecting amyloid beta oligomers
JP2017530373A5 (enExample)
WO2010021822A3 (en) Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
JP2012517017A5 (enExample)
JP2010521655A5 (enExample)
EA201071134A1 (ru) Анализ днк посредством капиллярного электрофореза
JP2013536442A5 (enExample)
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
JP2012501631A5 (enExample)
MX353566B (es) Metodos y sistemas para amplificacion de señal de bioensayos.
Iwasaki et al. Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C
MY149655A (en) Detection and enumeration of microorganisms
MA33040B1 (fr) Sondes d'oligonucleotides et amorces utiles dans la detection du virus de l'hepatite b
CN101603075A (zh) 一种基于酵母表面展示的分选酶检测的方法
EP1876445A4 (en) AGAINST GASTRIN RELEASING PEPTIDE PRECURSORS TARGETED ANTIBODIES
CN102071247B8 (zh) 一种区分非嗜肺与嗜肺军团菌的检测方法及试剂盒
GB0506183D0 (en) Antigen detection
GB2479279A (en) Recombinant antigen for detection of toxocariasis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 05 FEB 2017 BY COMPUTER PACKAGES INC

Effective date: 20140228

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2018 BY COMPUTER PACKAGES INC

Effective date: 20170118

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2019 BY ENVOY INTERNATIONAL LIMITED

Effective date: 20180116

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2020 BY RENEWALS TEAM

Effective date: 20181222

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2021 BY CPA GLOBAL

Effective date: 20200117

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2022 BY CPA GLOBAL

Effective date: 20210114

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2023 BY CPA GLOBAL

Effective date: 20211223

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2024 BY ANAQUA SERVICES

Effective date: 20230120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2025 BY ANAQUA SERVICES

Effective date: 20240123

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 FEB 2026 BY ANAQUA SERVICES

Effective date: 20250121